John Shuck, MD
Cardiovascular Disease · Dover, DENPI 1689641086
Payments from drug & device makers
What this record shows
11 manufacturers reported payments, led by Canon Medical Systems USA, Inc. at 54.4% of the total. Reporting peaked in 2021 at $1,845 and has fallen 75.3% since, to $456 in 2025. That places this record below the midpoint for cardiovascular disease clinicians in DE, where the typical reported total is $2,459.
Across 57 payments — averaging $54.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Canon Medical Systems USA, Inc.$2K
- Mentor Worldwide LLC$544
- AbbVie$277
- Medtronic$206
- Boston Scientific$120
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$74
- plus $193 from 5 others
What the payments were for
- Travel & lodging$1,61052%
- Food & beverage$1,48848%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Canon Medical Systems USA, Inc. | 10 | $1,684 |
| Mentor Worldwide LLC | 4 | $544 |
| AbbVie(2 entities) | 3 | $277 |
| Medtronic(2 entities) | 15 | $206 |
| Boston Scientific | 7 | $120 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $74 |
| Pfizer | 4 | $63 |
| AstraZeneca | 4 | $59 |
| E.r. Squibb & Sons, L.L.C. | 3 | $37 |
| Amarin Pharma, Inc. | 1 | $20 |
| Amgen | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,098 in reported general payments places this provider in the 50th percentile of 104 cardiovascular disease providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 77 | $109,005 |
| JardianceEmpagliflozin | 77 | $92,973 |
| XareltoRivaroxaban | 35 | $36,680 |
| EntrestoSacubitril/Valsartan | 21 | $34,502 |
| VascepaIcosapent Ethyl | 19 | $13,738 |
| BrilintaTicagrelor | 12 | $11,093 |
| Repatha SureclickEvolocumab | 15 | $7,744 |
| Rosuvastatin Calcium | 189 | $5,265 |
| Ezetimibe | 73 | $3,449 |
| Metoprolol Succinate | 139 | $2,072 |
| Ranolazine ErRanolazine | 18 | $1,787 |
| Amiodarone Hcl | 50 | $1,502 |
| Atorvastatin Calcium | 56 | $871 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 23 | $718 |
| Bumetanide | 13 | $697 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $63 | $109,00577 claims |
| AstraZenecaBrilinta | $59 | $11,09312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 104 cardiovascular disease providers in Delaware.
Other cardiovascular disease in Dover
- Eranga HaththotuwaDover$15K
- Gurmeet SinghDover$9K
- Michael SheaDover$6K
- Khaled EljazzarDover$3K
- Jennifer EakinDover$2K
- Vinay HosmaneWilmington$256K
- Wasif QureshiBear$122K
- Rajinder PrasadLewes$72K
- Ehtasham QureshiLewes$52K
- Edward GoldenbergNewark$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.